Robert B. Ford

Insider · Chairman and CEO · ABT

Robert B. Ford files insider transactions with the SEC as a chairman and ceo of Abbott Laboratories (ABT). We hold 2 disclosed purchases and sales filed since 3 July 2014, 1 of them in the last 90 days.

Files forABT
Disclosed buys and sells2 in all, 1 in the last 90 days
Last disclosure27 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 1 July 2014 — 25 August 2026Chairman and CEO · Abbott Laboratories (ABT)150 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

exercised options over 151,869 shares of Abbott LaboratoriesSEC Form 427 August 2026Common shares without par value · traded 25 August 2026 · filed 27 August 2026
exercised options over 246,963 shares of Abbott LaboratoriesSEC Form 427 August 2026Common shares without par value · traded 25 August 2026 · filed 27 August 2026
▼ sold on the open market 218,535 shares of Abbott LaboratoriesSEC Form 427 August 2026Common shares without par value · traded 25 August 2026 · filed 27 August 2026
▼ sold on the open market 180,297 shares of Abbott LaboratoriesSEC Form 427 August 2026Common shares without par value · traded 25 August 2026 · filed 27 August 2026
exercised options over 151,869 shares of Abbott Laboratories (a derivative holding)SEC Form 427 August 2026Option (right to buy) · traded 25 August 2026 · filed 27 August 2026
exercised options over 246,963 shares of Abbott Laboratories (a derivative holding)SEC Form 427 August 2026Option (right to buy) · traded 25 August 2026 · filed 27 August 2026
had shares withheld for tax on 30,308 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 27 February 2026 · filed 3 March 2026
had shares withheld for tax on 30,308 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 27 February 2026 · filed 3 March 2026
was granted 83,464 shares of Abbott LaboratoriesSEC Form 426 February 2026Common shares without par value · traded 24 February 2026 · filed 26 February 2026
was granted 344,066 shares of Abbott Laboratories (a derivative holding)SEC Form 426 February 2026Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
was granted 344,066 shares of Abbott Laboratories (a derivative holding)SEC Form 426 February 2026Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
was granted 83,464 shares of Abbott LaboratoriesSEC Form 426 February 2026Common shares without par value · traded 24 February 2026 · filed 26 February 2026
▲ bought on the open market 18,800 shares of Abbott LaboratoriesSEC Form 426 January 2026Common shares without par value · traded 23 January 2026 · filed 26 January 2026
▲ bought on the open market 18,800 shares of Abbott LaboratoriesSEC Form 426 January 2026Common shares without par value · traded 23 January 2026 · filed 26 January 2026
had shares withheld for tax on 31,651 shares of Abbott LaboratoriesSEC Form 44 March 2025Common shares without par value · traded 28 February 2025 · filed 4 March 2025
was granted 241,706 shares of Abbott Laboratories (a derivative holding)SEC Form 427 February 2025Option (right to buy) · traded 25 February 2025 · filed 27 February 2025
was granted 64,897 shares of Abbott LaboratoriesSEC Form 427 February 2025Common shares without par value · traded 25 February 2025 · filed 27 February 2025
exercised options over 285,388 shares of Abbott Laboratories (a derivative holding)SEC Form 47 February 2025Option (right to buy) · traded 5 February 2025 · filed 7 February 2025
exercised options over 285,388 shares of Abbott LaboratoriesSEC Form 47 February 2025Common shares without par value · traded 5 February 2025 · filed 7 February 2025
▼ sold on the open market 285,388 shares of Abbott LaboratoriesSEC Form 47 February 2025Common shares without par value · traded 5 February 2025 · filed 7 February 2025
exercised options over 127,436 shares of Abbott Laboratories (a derivative holding)SEC Form 413 September 2024Option (right to buy) · traded 12 September 2024 · filed 13 September 2024
exercised options over 14,243 shares of Abbott Laboratories (a derivative holding)SEC Form 413 September 2024Option (right to buy) · traded 12 September 2024 · filed 13 September 2024
exercised options over 127,436 shares of Abbott LaboratoriesSEC Form 413 September 2024Common shares without par value · traded 12 September 2024 · filed 13 September 2024
exercised options over 14,243 shares of Abbott LaboratoriesSEC Form 413 September 2024Common shares without par value · traded 12 September 2024 · filed 13 September 2024
▼ sold on the open market 80,299 shares of Abbott LaboratoriesSEC Form 413 September 2024Common shares without par value · traded 12 September 2024 · filed 13 September 2024
▼ sold on the open market 61,380 shares of Abbott LaboratoriesSEC Form 413 September 2024Common shares without par value · traded 12 September 2024 · filed 13 September 2024
had shares withheld for tax on 31,610 shares of Abbott LaboratoriesSEC Form 44 March 2024Common shares without par value · traded 29 February 2024 · filed 4 March 2024
was granted 264,293 shares of Abbott Laboratories (a derivative holding)SEC Form 423 February 2024Option (right to buy) · traded 21 February 2024 · filed 23 February 2024
was granted 70,332 shares of Abbott LaboratoriesSEC Form 423 February 2024Common shares without par value · traded 21 February 2024 · filed 23 February 2024
had shares withheld for tax on 30,742 shares of Abbott LaboratoriesSEC Form 42 March 2023Common shares without par value · traded 28 February 2023 · filed 2 March 2023
was granted 276,082 shares of Abbott Laboratories (a derivative holding)SEC Form 422 February 2023Option (right to buy) · traded 17 February 2023 · filed 22 February 2023
was granted 70,008 shares of Abbott LaboratoriesSEC Form 422 February 2023Common shares without par value · traded 17 February 2023 · filed 22 February 2023
exercised options over 45,492 shares of Abbott Laboratories (a derivative holding)SEC Form 426 August 2022Option (right to buy) · traded 25 August 2022 · filed 26 August 2022
exercised options over 56,933 shares of Abbott Laboratories (a derivative holding)SEC Form 426 August 2022Option (right to buy) · traded 25 August 2022 · filed 26 August 2022
exercised options over 45,492 shares of Abbott LaboratoriesSEC Form 426 August 2022Common shares without par value · traded 25 August 2022 · filed 26 August 2022
exercised options over 56,933 shares of Abbott LaboratoriesSEC Form 426 August 2022Common shares without par value · traded 25 August 2022 · filed 26 August 2022
▼ sold on the open market 102,425 shares of Abbott LaboratoriesSEC Form 426 August 2022Common shares without par value · traded 25 August 2022 · filed 26 August 2022
gave away 33,414 shares of Abbott LaboratoriesSEC Form 41 April 2022Common shares without par value · traded 25 March 2022 · filed 1 April 2022
gave away 33,414 shares of Abbott LaboratoriesSEC Form 41 April 2022Common shares without par value · traded 25 March 2022 · filed 1 April 2022
had shares withheld for tax on 26,579 shares of Abbott LaboratoriesSEC Form 42 March 2022Common shares without par value · traded 28 February 2022 · filed 2 March 2022
was granted 344,827 shares of Abbott Laboratories (a derivative holding)SEC Form 423 February 2022Option (right to buy) · traded 18 February 2022 · filed 23 February 2022
was granted 73,992 shares of Abbott LaboratoriesSEC Form 423 February 2022Common shares without par value · traded 18 February 2022 · filed 23 February 2022
gave away 28,746 shares of Abbott LaboratoriesSEC Form 42 July 2021Common shares without par value · traded 25 June 2021 · filed 2 July 2021
gave away 28,746 shares of Abbott LaboratoriesSEC Form 42 July 2021Common shares without par value · traded 25 June 2021 · filed 2 July 2021
had shares withheld for tax on 22,865 shares of Abbott LaboratoriesSEC Form 42 March 2021Common shares without par value · traded 26 February 2021 · filed 2 March 2021
was granted 359,090 shares of Abbott Laboratories (a derivative holding)SEC Form 423 February 2021Option (right to buy) · traded 19 February 2021 · filed 23 February 2021
was granted 70,058 shares of Abbott LaboratoriesSEC Form 423 February 2021Common shares without par value · traded 19 February 2021 · filed 23 February 2021
gave away 20,918 shares of Abbott LaboratoriesSEC Form 422 May 2020Common shares without par value · traded 15 May 2020 · filed 22 May 2020
gave away 20,918 shares of Abbott LaboratoriesSEC Form 422 May 2020Common shares without par value · traded 15 May 2020 · filed 22 May 2020
had shares withheld for tax on 16,638 shares of Abbott LaboratoriesSEC Form 43 March 2020Common shares without par value · traded 28 February 2020 · filed 3 March 2020
was granted 390,896 shares of Abbott Laboratories (a derivative holding)SEC Form 425 February 2020Option (right to buy) · traded 21 February 2020 · filed 25 February 2020
was granted 64,124 shares of Abbott LaboratoriesSEC Form 425 February 2020Common shares without par value · traded 21 February 2020 · filed 25 February 2020
gave away 18,833 shares of Abbott LaboratoriesSEC Form 410 June 2019Common shares without par value · traded 6 June 2019 · filed 10 June 2019
gave away 18,833 shares of Abbott LaboratoriesSEC Form 410 June 2019Common shares without par value · traded 6 June 2019 · filed 10 June 2019
had shares withheld for tax on 14,682 shares of Abbott LaboratoriesSEC Form 44 March 2019Common shares without par value · traded 28 February 2019 · filed 4 March 2019
was granted 240,059 shares of Abbott Laboratories (a derivative holding)SEC Form 426 February 2019Option (right to buy) · traded 22 February 2019 · filed 26 February 2019
was granted 45,797 shares of Abbott LaboratoriesSEC Form 426 February 2019Common shares without par value · traded 22 February 2019 · filed 26 February 2019
had shares withheld for tax on 299 shares of Abbott LaboratoriesSEC Form 45 June 2018Common shares without par value · traded 1 June 2018 · filed 5 June 2018
gave away 15,280 shares of Abbott LaboratoriesSEC Form 49 March 2018Common shares without par value · traded 6 March 2018 · filed 9 March 2018
gave away 15,280 shares of Abbott LaboratoriesSEC Form 49 March 2018Common shares without par value · traded 6 March 2018 · filed 9 March 2018
had shares withheld for tax on 10,721 shares of Abbott LaboratoriesSEC Form 42 March 2018Common shares without par value · traded 28 February 2018 · filed 2 March 2018
was granted 44,909 shares of Abbott LaboratoriesSEC Form 421 February 2018Common shares without par value · traded 16 February 2018 · filed 21 February 2018
was granted 246,963 shares of Abbott Laboratories (a derivative holding)SEC Form 421 February 2018Option (right to buy) · traded 16 February 2018 · filed 21 February 2018
exercised options over 4,467 shares of Abbott Laboratories (a derivative holding)SEC Form 41 February 2018Option (right to buy) · traded 30 January 2018 · filed 1 February 2018
exercised options over 10,400 shares of Abbott Laboratories (a derivative holding)SEC Form 41 February 2018Option (right to buy) · traded 30 January 2018 · filed 1 February 2018
exercised options over 19,600 shares of Abbott Laboratories (a derivative holding)SEC Form 41 February 2018Option (right to buy) · traded 30 January 2018 · filed 1 February 2018
exercised options over 49,000 shares of Abbott Laboratories (a derivative holding)SEC Form 41 February 2018Option (right to buy) · traded 30 January 2018 · filed 1 February 2018
exercised options over 4,467 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
exercised options over 10,400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
exercised options over 19,600 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
exercised options over 49,000 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 300 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 527 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 1,100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,700 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 200 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,000 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 1,000 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 1,346 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 3,600 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 5,303 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 21,789 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 5,570 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 17,686 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,443 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 301 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 1,400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 202 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 3,000 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 1,300 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 100 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 2,400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 400 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
▼ sold on the open market 600 shares of Abbott LaboratoriesSEC Form 41 February 2018Common shares without par value · traded 30 January 2018 · filed 1 February 2018
had shares withheld for tax on 1,618 shares of Abbott LaboratoriesSEC Form 45 July 2017Common shares without par value · traded 1 July 2017 · filed 5 July 2017
had shares withheld for tax on 352 shares of Abbott LaboratoriesSEC Form 42 June 2017Common shares without par value · traded 1 June 2017 · filed 2 June 2017
gave away 10,670 shares of Abbott LaboratoriesSEC Form 417 March 2017Common shares without par value · traded 16 March 2017 · filed 17 March 2017
gave away 10,670 shares of Abbott LaboratoriesSEC Form 417 March 2017Common shares without par value · traded 16 March 2017 · filed 17 March 2017
had shares withheld for tax on 8,685 shares of Abbott LaboratoriesSEC Form 42 March 2017Common shares without par value · traded 28 February 2017 · filed 2 March 2017
was granted 21,959 shares of Abbott LaboratoriesSEC Form 422 February 2017Common shares without par value · traded 17 February 2017 · filed 22 February 2017

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.